Home › Categories › Corporate Reports› Endotoxin Detection

Endotoxin Detection.pdf

bioMrieux-acquires-Hyglos.pdf

🔗 Source: horseshoecrab.org

📊 Size: 70 KB

👤 Author: Glenn Gauvry

⬇️ Downloads: 207

Summary

bioMérieux acquires Hyglos, expanding its offerings to detect endotoxins in pharmaceutical products. Hyglos, founded in 2009, specializes in detecting endotoxins using recombinant proteins. Endotoxins, found in Gram-negative bacteria, can cause high fevers and must be absent from pharmaceutical products. Current detection methods rely on horseshoe crab blood, but Hyglos' innovative method uses recombinant proteins, eliminating the need for crab blood.

Hyglos' technology can also "demask" endotoxins hidden by certain formulations in biotechnological medicines. The acquisition enriches bioMérieux's microbiological control solutions for the pharmaceutical industry and medical devices. The endotoxin detection market is estimated at €250 million, growing 12% annually, driven by biotechnology, medical devices, and vaccines. bioMérieux paid €24 million for 100% of Hyglos' shares, phased over 3 years, with consolidation starting June 1, 2016.

Download File

Description

bioMérieux acquires Hyglos to expand detection of endotoxins in pharmaceutical products.
Hyglos specializes in detecting endotoxins using recombinant proteins.
Endotoxins can cause high fevers and must be absent from certain pharmaceuticals.

Technical Information

File Format: PDF
File Size: 70 KB
Pages: 2
Language: EN
Author: Glenn Gauvry
Total Downloads: 207
Last Updated: 1 week ago

Document Overview

This PDF document about Endotoxin Detection provides comprehensive information and guidance. Whether you're a beginner or advanced user, this resource offers valuable insights into Endotoxin Detection.